Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
Bülent Polat(University of Würzburg), Camelia‐Maria Monoranu(University of Würzburg)
Cited by 23
Related Papers
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|536
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|349
α-Synuclein in Parkinson’s disease: causal or bystander?
|Journal of Neural Transmission|2019|114